Petco Health and Wellness Company, Inc. (WOOF) Stock Price & Analysis
Petco Health and Wellness Company, Inc. (WOOF) closed at USD 2.53 on Thursday, October 22, 2026, up 9.52% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 2.31; the Oct 22, 2026 session ranged USD 2.3–2.55 on volume of 4,834,884 shares. Market capitalization is $724.64M, with a 52-week range of USD 2.14–3.87 (NMS). Source: Nexqual, retrieved October 23, 2026 at 10:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/WOOF.md
Key facts (WOOF)
- Last four reported quarters (through Aug 1, 2026): revenue $5.97B, net income $30.3M (0.5% margin), free cash flow $238M (SEC filings).
- Valuation: P/E 23.9x (avg 84.9x at the last 1 fiscal year-ends), EV/EBITDA 3.1x, net debt $297M.
- Analysts: Hold (mean 3.08 on a 1–5 scale) (12 analysts), mean target USD 3.47 (range 2.11–5).
- Total return with dividends: 1Y -31.6% vs S&P 500 +14.9%; 5Y -89.3% vs S&P 500 +80.3%.
- Next earnings: 2026-09-02, EPS estimate USD 0.04, revenue estimate $1.48B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (WOOF)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.81B | $6.04B | $6.26B | $6.12B | $5.96B | $5.97B |
| Gross profit | $2.43B | $2.43B | $2.35B | $2.32B | $2.31B | — |
| Operating income | $266M | $226M | -$1.18B | $7.1M | $120M | $133M |
| Net income | $164M | $90.8M | -$1.28B | -$102M | $9.1M | $30.3M |
| EPS (diluted) | $0.62 | $0.34 | -$4.78 | -$0.37 | $0.03 | — |
| Free cash flow | $119M | $68.0M | -$9.9M | $49.7M | $187M | $238M |
| Gross margin | 41.8% | 40.2% | 37.6% | 38.0% | 38.7% | — |
| Operating margin | 4.6% | 3.7% | -18.9% | 0.1% | 2.0% | 2.2% |
| Net margin | 2.8% | 1.5% | -20.5% | -1.7% | 0.2% | 0.5% |
| Revenue growth | +18.0% | +3.9% | +3.6% | -2.2% | -2.5% | — |
| Cash + short-term investments | $212M | $202M | $125M | $166M | $257M | — |
| Total debt | $1.64B | $1.63B | $1.58B | $1.58B | $1.49B | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Aug 1, 2026) (WOOF)
P/E 23.9x · P/S 0.1x · EV/EBITDA 3.1x · EV/Sales 0.2x · P/FCF 3.0x · P/B 0.6x · FCF yield 32.82% · Earnings yield 4.18% · Net debt $297M · EV $1.02B
P/E at fiscal year-ends: Jan 2026 84.9x.
Analysts (WOOF)
Consensus Hold (mean 3.08 on a 1–5 scale), 12 analysts; mean target USD 3.47 (low 2.11, high 5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-29 | Evercore ISI Group | Target lowered | In-Line | $4 → $3 |
| 2026-09-03 | BNP Paribas | Target lowered | Underperform | $2.34 → $2.11 |
| 2026-09-03 | UBS | Target lowered | Neutral | $4 → $3.5 |
| 2026-09-03 | Baird | Target raised | Neutral | $3 → $3.25 |
| 2026-09-01 | Evercore ISI Group | Target raised | In-Line | $3.5 → $4 |
Total return (dividends reinvested) (WOOF)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -31.6% | -89.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -31.7% | -36.0% |
| Volatility (annualized) | 57.8% | 69.4% |
| Max drawdown | -42.9% (Oct 2025→Oct 2026) | -94.1% (Nov 2021→Apr 2024) |
WOOF analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Oct 2026) | $0.04 | $0.06 | -21.6% | $1.48B | 7 |
| Next quarter (ends Jan 2027) | $0.06 | $0.08 | -23.6% | $1.53B | 7 |
| Current fiscal year (ends Jan 2027) | $0.26 | $0.22 | +16.0% | $5.99B | 8 |
| Next fiscal year (ends Jan 2028) | $0.27 | $0.28 | -3.7% | $6.06B | 8 |
Key Statistics (as of October 23, 2026 at 10:11 UTC)
| Price | USD 2.53 |
|---|---|
| Change | ▲ 9.52% (up) |
| Previous Close | USD 2.31 |
| Open | USD 2.32 |
| Day Range | USD 2.3 – 2.55 |
| 52-Week Range | USD 2.14 – 3.87 |
| Volume | 4,834,884 shares |
| Market Cap | $724.64M |
| Exchange | NMS |
Technical Analysis (WOOF)
Nexqual's technical model rates WOOF "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 10:11 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 60.1 (neutral) |
| vs SMA50 | Above (USD 2.48) |
| MACD | -0.01 (negative) |
Analyst Ratings (WOOF)
Wall Street analysts rate WOOF "Hold" based on 12 analysts, with a mean price target of USD 3.47 (range USD 2.11–5), per Nexqual as of October 23, 2026 at 10:11 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 12 |
| Mean Target | USD 3.47 |
| High Target | USD 5 |
| Low Target | USD 2.11 |
| Buy / Hold / Sell | 2 / 8 / 2 |
Earnings (WOOF)
| Next Earnings Date | 2026-09-02 |
|---|---|
| EPS Estimate | USD 0.04 |
| Revenue Estimate | $1.48B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-07-31 | USD 0.15 vs est 0.07 ▲ beat |
| 2026-04-30 | USD 0.03 vs est 0.03 ▼ miss |
| 2026-01-31 | USD 0.04 vs est 0.04 ▲ beat |
| 2025-10-31 | USD 0.04 vs est 0.02 ▲ beat |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financials & Fundamentals (WOOF)
| Total Revenue | $5.97B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +0.00% |
| Gross Margin | +38.81% |
| Operating Margin | +3.21% |
| Profit Margin | +0.51% |
| ROE | +2.58% |
| Debt / Equity | 2.34 |
| Current Ratio | 0.9 |
| Total Cash | $293.77M |
| Total Debt | $2.82B |
| Free Cash Flow (last four quarters to Aug 2026, SEC 10-Q / 10-K) | $237.83M (4.0% of revenue) |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financial Health Score (WOOF)
Nexqual rates Petco Health and Wellness Company, Inc.'s overall financial health "Weak" across five dimensions, as of October 23, 2026 at 10:11 UTC.
| Growth | Weak — Revenue -3% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 39%, operating 3% (last 12 months) |
| Balance Sheet | Critical — $293M cash and investments vs $591M debt (Aug 2026, SEC) |
| Cash Flow | Mixed — FCF $238M (last 4 quarters to Aug 2026, SEC), slim 4.0% margin |
| Efficiency | Weak — ROE 3%, ROA 1.6% |
Ownership (WOOF)
| Insider Ownership | +3.31% |
|---|---|
| Institutional Ownership | +121.43% |
| Shares Outstanding | 248.63M |
| Float | 91.55M |
| Short % of Float | +20.13% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Leadership (WOOF)
Petco Health and Wellness Company, Inc. is led by Joel D. Anderson, CEO & Director, per Nexqual as of October 23, 2026 at 10:11 UTC.
| CEO & Director | Joel D. Anderson |
|---|---|
| Chief Financial Officer | Sabrina Louise Simmons |
| Chief Revenue Officer | Patrick Joseph Venezia |
| Chief Strategy & Transformation Officer | Dan Calista |
Major Backers & Investors (WOOF)
Notable institutional backers of Petco Health and Wellness Company, Inc. include Canada Pension Plan Investment Board, Long Focus Capital Management, LLC, Two Sigma Investments, LP, according to Nexqual as of October 23, 2026 at 10:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Canada Pension Plan Investment Board | 24.04% |
| Long Focus Capital Management, LLC | 3.37% |
| Two Sigma Investments, LP | 2.24% |
| Holocene Advisors, LP | 1.97% |
| Cresset Asset Management, LLC | 1.55% |
| FMR, LLC | 1.54% |
| Fidelity | 1.49% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Dimensional Fund Advisors | 4.45% |
| BlackRock | 3.25% |
| Vanguard Group | 1.55% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BWMX | Betterware de Mexico, S.A.P.I. | USD 15.98 | ▲ 0.57% |
| WINA | Winmark Corporation | USD 285.97 | ▲ 1.85% |
| BNED | Barnes & Noble Education, Inc | USD 13.95 | ▲ 1.45% |
| HZO | MarineMax, Inc. (FL) | USD 52.38 | ▼ 0.08% |
| EYE | National Vision Holdings, Inc. | USD 18.87 | ▲ 6.49% |
| SVV | Savers Value Village, Inc. | USD 9.85 | ▼ 0.3% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt